An Opportunity To Generate Profits For Investors:: CVS Health Corporation, (NYSE: CVS)

Desiree Burns
December 1, 2018

Jupiter Asset Management Ltd.'s holdings in CVS Health were worth $11,143,000 as of its most recent filing with the Securities and Exchange Commission. Assetmark Inc. now owns 5,319 shares of the pharmacy operator's stock worth $419,000 after purchasing an additional 665 shares in the last quarter. CVS has a beta of 0.93.

Other institutional investors have also recently added to or reduced their stakes in the company. Intersect Capital LLC grew its position in CVS Health by 6.1% in the 3rd quarter. Boston Partners now owns 9,908,888 shares of the pharmacy operator's stock worth $637,637,000 after acquiring an additional 2,924,875 shares during the last quarter. Schwab Charles Investment Management Inc. grew its holdings in CVS Health by 4.3% during the 2nd quarter. Hayek Kallen Investment Management now owns 13,567 shares of the pharmacy operator's stock valued at $844,000 after purchasing an additional 641 shares in the last quarter. BlackRock Inc. increased its position in CVS Health by 5.9% during the 2nd quarter.

A number of brokerages have issued reports on CVS. Cantor Fitzgerald initiated CVS Health Corporation (NYSE:CVS) rating on Monday, November 26. Morgan Stanley maintained it with "Overweight" rating and $80 target in Tuesday, July 3 report. But the stock owners and investors want to make the profit and that is the only reason why they buy and sell these shares. In the context of a single stock trading on a stock exchange, the volume is commonly reported as the number of shares that changed hands during a given day. Royal Bank of Canada restated a buy rating and issued a $90.00 price target on shares of CVS Health in a research note on Wednesday, August 8th.

The Stock now has Analyst' mean Recommendation of 2.6 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell. CVS Health presently has an average rating of "Buy" and an average price target of $90.04. Also, EVP Lisa Bisaccia sold 21,534 shares of the stock in a transaction that occurred on Monday, October 1st. The average volume was noted at 7524.91K shares while its relative volume was seen at 1.57. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 14,229 shares were sold by Brennan Troyen A, worth $1.17M on Wednesday, November 14.

At times when price is in a downtrend and the moving average is in a downtrend as well, and price tests the SMA above and is rejected a few consecutive times (i.e. the moving average is serving as a resistance line), then a trader might sell on the next rally up to the Simple Moving Average. The disclosure for this sale can be found here.

Market capitalization refers to the total dollar market value of a company's outstanding shares.

More important recent CVS Health Corporation (NYSE:CVS) news were published by: which released: "CVS sees Aetna deal closing after Thanksgiving" on November 20, 2018, also published article titled: "CVS Health: Becoming A Healthcare Powerhouse", published: "Pre-Open Movers 11/26: (RSLS) (JKS) (NVAX) Higher; (PLT) (MDT) Lower (more...)" on November 26, 2018.

Mueller might file new charges against Manafort
The legal team alerted the Justice Department, but privately was put off by a reference to Trump in the document, the person said. And they don't directly accuse the president of any criminal wrongdoing or indicate that the president faces legal jeopardy.

The 10 analysts offering 12-month price forecasts for Investors Bancorp Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 12.00.

In the liquidity ratio analysis; current ratio was 2.4 while Total Debt/Equity ratio was 1.72.

The stock has a beta of 0.93 compared to a beta of 1 for the market, which implies that the stock's price movements are less extreme than the market as a whole. The Illinois-based Gp One Trading Lp has invested 0.02% in CVS Health Corporation (NYSE:CVS).

Experts experienced mean rating at 1.9 following consensus analysis. The company had revenue of $47.27 billion during the quarter, compared to analyst estimates of $47.22 billion.

The EPS of CVS is strolling at 1.56, measuring its EPS growth this year at 1.8%. As of now, CVS has a P/S, P/E and P/B values of 0.43, 50.86 and 2.21 respectively. CVS stock is now showing down return of 1.21 throughout last week and witnessed bearish return of 13.38 in one month period. Investors of record on Wednesday, October 24th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date was Tuesday, October 23rd. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. If you are reading this news story on another website, it was stolen and reposted in violation of U.S. and worldwide copyright & trademark laws. The legal version of this piece can be read at

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Other reports by

Discuss This Article